Company name
2022Founder
Adam Kroetsch works on systemic reforms to make clinical trials faster and less costly, including through changes to policy, infrastructure, incentives, and business models. They draw on more than a decade at the FDA and write about trial efficiency, drug regulation, and ways to improve clinical evidence.